Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Solution concentration of nadroparin calcium determined by phenanthroline-zinc sulfate ultraviolet spectroscopy

A technology of phenanthroline and ultraviolet spectroscopy, which is applied in the field of rapid quantitative determination of the concentration of nadroparin calcium solution, can solve problems such as inability to apply and large analytical errors, and achieve the effect of good anti-interference ability.

Active Publication Date: 2013-06-12
SHENZHEN SCIPROGEN BIO PHARMA
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] On the other hand, at present, the initial source of heparin drugs at home and abroad is mainly animal raw materials such as pig small intestinal mucosa, which has regional differences and has a large range of changes in nitrogen content, sulfur content, and glycosyl sequence.
At the same time, nadroparin calcium drug is actually just a polymer mixture with a specified molecular weight range and other main properties. Therefore, the detection method for nadroparin calcium must have strong anti-interference ability, otherwise it will not be accurate during the detection process of actual samples. , will produce large analysis errors, and the obtained test results will not be applied to the process control and guide the follow-up process

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solution concentration of nadroparin calcium determined by phenanthroline-zinc sulfate ultraviolet spectroscopy
  • Solution concentration of nadroparin calcium determined by phenanthroline-zinc sulfate ultraviolet spectroscopy
  • Solution concentration of nadroparin calcium determined by phenanthroline-zinc sulfate ultraviolet spectroscopy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0032] The embodiment discloses the determination of the solution concentration of nadroparin calcium by o-phenanthroline-zinc sulfate ultraviolet spectroscopy. First, the applicability of the o-phenanthroline-zinc sulfate system, the anti-interference ability to calcium ions, and the The influence of the dosage of sodium acetate solution, the influence of the dosage of o-phenanthroline and the influence of the dosage of sodium nitrite solution, to illustrate the applicability, variable range and detection principle of the detection system; Concentration standard working curve, Experiment 7 verified the reliability of the method and the standard working curve through experiments.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses solution concentration of nadroparin calcium determined by phenanthroline-zinc sulfate ultraviolet spectroscopy. Under the environment of buffered solution, Ultraviolet absorbance degrees of mixed solution which includes Zn2+ions, phenanthroline and the nadroparin calcium are determined, and then the concentration of the nadroparin calcium is determined by quantity. According to the solution concentration of the nadroparin calcium determined by the phenanthroline-zinc sulfate ultraviolet spectroscopy, a phenanthroline-zinc sulfate ultraviolet spectroscopy test system is applied, quick quantitative determination of the solution concentration of the nadroparin calcium can be achieved. The linear range of an analytical method of the solution concentration of the nadroparin calcium determined by the phenanthroline-zinc sulfate ultraviolet spectroscopy is 1.184%-16.33%, meanwhile, the analytical method of the solution concentration of the nadroparin calcium determined by the phenanthroline-zinc sulfate ultraviolet spectroscopy has good anti-jamming capability and can be applied in the practical production process of nadroparin calcium medicines and capable of carrying out concentration determination to intermediate product solution or finished product solution.

Description

technical field [0001] The invention belongs to the production field of nadroparin calcium medicine, and in particular relates to a method for rapidly and quantitatively measuring the concentration of nadroparin calcium solution by using o-phenanthroline-zinc sulfate ultraviolet spectroscopy. Background technique [0002] Heparin is a mucopolysaccharide sulfate composed of D-glucosamine, L-iduronic acid, N-acetylglucosamine and glucuronic acid alternately, with a molecular weight from 5 to 30kDa, of which the sulfate radical accounts for about 40%. Typically, heparins originate primarily from porcine and bovine intestinal mucosa and lungs. In today's medicine, heparin is mainly used as an anticoagulant. It was officially used in clinical treatment in 1953 and is considered to be the most effective and clinically used anticoagulant drug. Unfractionated Heparin was initially used. By the end of the last century, unfractionated heparin was prepared into heparin derivatives w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N21/33
Inventor 陈贤光郑华淦张涤平吴园园曲和之盛光阳
Owner SHENZHEN SCIPROGEN BIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products